Allosteric Modulation of Related Ligand-Gated Ion Channels Synergistically Induces Long-Term Potentiation in the Hippocampus and Enhances Cognition
- 15 December 2010
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 336 (3), 908-915
- https://doi.org/10.1124/jpet.110.176255
Abstract
α5 Subunit-containing GABAA receptors (GABAARs) and α7 neuronal nicotinic-acetylcholine receptors (nAChRs) are members of the Cys-loop family of ligand-gated ion channels (LGICs) that mediate cognitive and attentional processes in the hippocampus. α5 GABAARs alter network activity by tonic inhibition of CA1/CA3 pyramidal cells of the hippocampus. Postsynaptic α7 nAChRs in the hippocampus regulate inhibitory GABAergic interneuron activity required for synchronization of pyramidal neurons in the CA1, whereas presynaptic α7 nAChRs regulate glutamate release. Can simultaneous allosteric modulation of these LGICs produce synergistic effects on cognition? We show that combined transient application of two allosteric modulators that individually 1) inhibit α5 GABAARs and 2) enhance α7 nAChRs causes long-term potentiation (LTP) of mossy fiber stimulation-induced excitatory postsynaptic currents (EPSC) from CA1 pyramidal neurons of rat hippocampal slices. The LTP effect evoked by two compounds is replicated by 3-(2,5-difluorophenyl)-6-(N-ethylindol-5-yl)-1,2,4-triazolo[4,3-b]pyridazine (522-054), a compound we designed to simultaneously inhibit α5 GABAARs and enhance α7 nAChRs. Selective antagonists for either receptor block sustained EPSC potentiation produced by 522-054. In vivo, 522-054 enhances performance in the radial arm maze and facilitates attentional states in the five-choice serial reaction time trial with similar receptor antagonist sensitivity. These observations may translate into therapeutic utility of dual action compounds in diseases of hippocampal-based cognitive impairment.Keywords
This publication has 49 references indexed in Scilit:
- Initial Phase 2 Trial of a Nicotinic Agonist in SchizophreniaAmerican Journal of Psychiatry, 2008
- The partial α7 nicotine acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampusNeuropharmacology, 2008
- Which GABAAReceptor Subunits Are Necessary for Tonic Inhibition in the Hippocampus?Journal of Neuroscience, 2008
- Blockade of alcohol's amnestic activity in humans by an α5 subtype benzodiazepine receptor inverse agonistNeuropharmacology, 2007
- α5GABAA Receptors Regulate the Intrinsic Excitability of Mouse Hippocampal Pyramidal NeuronsJournal of Neurophysiology, 2007
- Nootropic α7 nicotinic receptor allosteric modulator derived from GABA A receptor modulatorsProceedings of the National Academy of Sciences of the United States of America, 2007
- Synaptic and nonsynaptic localization of GABAA receptors containing the α5 subunit in the rat brainJournal of Comparative Neurology, 2006
- Proof-of-Concept Trial of an α7 Nicotinic Agonist in SchizophreniaArchives of General Psychiatry, 2006
- The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's diseaseHealth Technology Assessment, 2006
- Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2006